Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

67%

6 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

5(71.4%)

Phase 3

1(14.3%)

N/A

1(14.3%)

7Total

Phase 4(5)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06281899Phase 4Recruiting

Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT03415074Not ApplicableUnknown

Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD)

Role: lead

NCT02225886Phase 4Unknown

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Role: lead

NCT01785355Unknown

The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients

Role: lead

NCT02345759Unknown

Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease

Role: lead

NCT00384657Phase 3Withdrawn

Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease

Role: lead

NCT00551603Phase 4Withdrawn

Anaemia Correction in Haemodialyzed Patients - Comparative Analysis of Two Erythropoietin Stimulating Agents Schedules

Role: lead

NCT02031224Phase 4Completed

Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease

Role: lead

NCT00407641Phase 4Withdrawn

Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

Role: lead

All 9 trials loaded